Compare CVS Health Corp (CVS) vs PayPal Holdings, Inc. (PYPL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs PayPal Holdings, Inc. — how do they compare? CVS Health Corp trades at $86.25 (market cap $112.49B), while PayPal Holdings, Inc. trades at $54.99 (market cap $47.01B). The key difference: CVS Health Corp is far larger — about 2.4× PayPal Holdings, Inc.'s market cap, and CVS Health Corp pays the higher dividend (3.02%). Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and PayPal Holdings, Inc. for 106 Days on average.
| CVS | PYPL | |
|---|---|---|
Market Cap | $112.49B | $47.01B |
Volume | 8,467,392 | 10,493,459 |
Sector | Health | Financials |
52-Week High | $110.60 | $75.75 |
52-Week Low | $70.08 | $39.08 |
Typical Hold Time | 83 Days | 106 Days |
Enterprise Value | $174.83B | $49.15B |
Dividend Yield | 3.02% | 1.02% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.80, up 1.59% today, with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 27% upside. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $2.58 surpassing the $1.87 estimate. Revenue growth remains solid, reaching $402.07B in 2025, though net margins compressed to 1.18%. The technical picture shows bullish momentum with current price near key support at $87.
CVS presents a compelling value opportunity with attractive valuation multiples (P/E 23.21, P/S 0.27) and dividend stability, but faces margin pressure from healthcare cost trends. The stock's upside depends on maintaining earnings momentum amid reimbursement challenges and regulatory scrutiny highlighted in recent legal investigations.
PayPal (PYPL) trades at $55.02, up 0.75% on the day, with a bullish technical signal supported by moving averages. The stock shows strong fundamentals with a P/E of 10.39 and net income margin of 14.36%, while recent earnings beat expectations in two of the last three quarters. Positive sentiment is fueled by a new partnership with Meta and ongoing cost-saving initiatives under CEO Enrique Lores.
The outlook is cautiously optimistic, with a consensus price target of $56.47 offering modest upside. Key opportunities include Venmo growth and AI integration, but risks involve competitive pressures in digital payments and slowing branded checkout growth. Wall Street sentiment is mixed, with 35.71% of analysts rating it a buy.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About PayPal Holdings, Inc.
PayPal Holdings, Inc. operates as a technology platform company that enables digital and mobile payments on behalf of consumers and merchants. The Company offers online payment solutions. PayPal Holdings serves customers worldwide.
Read more on PYPL →
